Understanding the diagnostic landscape in the UK: challenges facing comercialisation teams and top tips to achieve market access
Read More
We explore some of the key themes o the agenda for The MedTech Forum from MDR to Digital Twins
What does it take to bring a cannabinoid pharmaceutical to market? On Tuesday 23rd May Clare Foy (Global Market Access Director – Mtech Access) was joined by Michael Sassano (CEO...
Read More
What are surrogate endpoints and how can they support the accelerated approval of new medicines? Where and how are surrogate endpoints being used? In which disease areas and markets can...
Read More
Jodie Worrall recently joined Mtech Access as an Associate Director, leading our Evidence Synthesis and Systematic Review team alongside Shona Lang. In this interview, we learn about her expertise, her travels and what its been like returning to consultancy, at Mtech Access.
Helen Lilley tells us about her experiences and activities as a medical writer at Mtech Access, supporting projects from local communication materials to global value dossiers to HTA submissions.
How will changes to the structure of primary care impact decision making? How is the relationship between Integrated Care Boards (ICBs) and primary care stakeholders evolving? How will funding flows...
Read More
Heather Wellam (Senior Consultant – Market Access) explains the cost-effectiveness analysis process in Japan, answering FAQs and exploring challenges and opportunities.
As our developers experiment with integrating AI into our tools, we demonstrate the potential (and current limitations) of this technology with ChatGPT
Abigail Beveridge recently joined Mtech Access as a Medical Writer in our Manchester office. In this interview, we ask about her experiences and activities in her first few weeks with us.
